LEXINGTON, Mass.–(BUSINESS WIRE)–Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra), a biotechnology company devoted to discovering and developing innovative therapies designed to treat immune-mediated and metabolic diseases, today announced that To…
Viridian Therapeutics Highlights Recent Progress and Reports Second Quarter 2025 Financial Results
WALTHAM, Mass.–(BUSINESS WIRE)–Viridian Therapeutics, Inc. (Nasdaq: VRDN), a biotechnology company focused on discovering, developing and commercializing potential best-in-class medicines for serious and rare diseases, today reported recent business …
National Vision Holdings, Inc. Reports Second Quarter 2025 Financial Results
DULUTH, Ga.–(BUSINESS WIRE)–National Vision Holdings, Inc. (NASDAQ: EYE) (“National Vision,” “we,” “our,” “us” or the “Company”) today reported its financial results for the second quarter ended June 28, 2025. “Our strong performance this quarter ref…
Uncategorized
When do you consider surgery for patients with thyroid eye disease?
Click here to read the Cover Story, ” Treatment for thyroid eye disease in an exciting era of growth . “Surgery is considered in either of the two following situations:The first thing to keep in mind when thinking about thyroid eye disease is that ther…
Uncategorized
Alcon to acquire STAAR Surgical
Editor’s note: This is a developing news story. Please check back soon for updates.Alcon plans to acquire STAAR Surgical through a definitive merger agreement, according to a press release.The acquisition is expected to be complete in approximately 6 t…
Retina Tear Raises Detachment Risk After Cataract Surgery
Delaying cataract surgery 6 months or more after laser for retina tears reduces the risk for retinal detachment by half, a new study shows. Medscape Medical News